Scientist Meng-Er Huang; Institut Curie (IC) is a private nonprofit organization created in 1909 which combines a leading European cancer research center;_WJD_2019-0721_

--- -  - --- -  - ---
2019-07-21
Scientist Meng-Er Huang; Institut Curie (IC) is a private nonprofit organization created in 1909 which combines a leading European cancer research center;_WJD_2019-0721_V001R01_IR94_RvD20190721_

Source (資訊來源):
https://science.institut-curie.org/research/biology-chemistry-of-radiations-cell-signaling-and-cancer-axis/umr3348-genotoxic-stress-and-cancer/equipe-huang/
Info cited on 2019-07-21-WD7 (資訊引用於 中華民國108年7月21日) by 湯偉晉 (WeiJin Tang)
#

Source (資訊來源):
https://science.institut-curie.org/research/biology-chemistry-of-radiations-cell-signaling-and-cancer-axis/umr3348-genotoxic-stress-and-cancer/equipe-huang/team-members/?mbr=meng-er-huang-md-phd
Info cited on 2019-07-21-WD7 (資訊引用於 中華民國108年7月21日) by 湯偉晉 (WeiJin Tang)
#

- -  - - - -  - -

OXIDATIVE STRESS, REDOX REGULATION AND CELL FATE
PARTAGER

#

#

Huang
Meng-Er Huang
Team Leader
meng-er.huang@curie.fr
Tel: +33 (0)1 69 86 30 16

Reactive oxygen species (ROS) and dynamic intracellular reductive/oxidative (redox) balance are critical for normal cellular functions. Disruption of redox homeostasis leads to aberrant cell signaling, macromolecules damage and is associated with human pathologies such as neuro-degenerative diseases and cancers.

Our team has been conducting research to better understand redox regulation, oxidative stress response mechanisms, and ROS induced genome instability and cell death. We use two complementary experimental systems, human cell lines and the yeast S. cerevisiae to investigate these mechanisms.

#

#

Figure 1: Schematic illustration of cellular redox homeostasis. Major reactive oxygen species (ROS) and antioxidant elements are indicated (upper panel). SOD, superoxide dismutases; PRX, peroxiredoxins; TRX, thioredoxins; GRX, glutaredoxins; GPX, glutathione peroxidases; GSH, glutathione. ROS are involved in cell signalling, whereas a severe and prolonged increase of ROS cause oxidative stress (lower panel).
Our current research activities focus on the following projects. The project I is to study the biological function of oxidative stress response system (Figure 1), including peroxiredoxins, thioredoxins and glutathione regarding genome stability maintenance and cell death regulation in yeast and in human cells. These elements are not only the first line of defence against deleterious effect of oxidative stress but also actively involved in redox signaling. More recently, we focused our effort on characterizing the subcellular compartments redox environments and their dynamic regulations in various biological processes (Figure 2). The project II is to understand the physiological role of the S. cerevisiae protein complex Tah18/Dre2 and to define its biochemical properties. This protein complex exhibits functional interaction with the DNA polymerase delta and may be implicated in linking intracellular redox states to cell fate. We wish to understand more precisely how this complex is linked to DNA replication via iron-sulfur (Fe-S) biosynthesis. The project III aims to exploits redox-modulating strategies as a therapeutic approach. Therapeutic selectivity in cancer therapy could be achieved by ROS-mediated mechanisms based on the different redox states in normal and malignant cells. We are studying whether and how a rational redox modulation could have selective and synergistic effects together with treatment by drugs or ionizing radiations in cancer cells.

Figure 2: Adressage de sondes rédox fluorescentes (rxYFP) dans les compartiments cytosolique, nucléaire et mitochondrial (matrice) de cellules HeLa (panneau supérieur). Analyse au cours du temps des changements rédox au sein des différents compartiments cellulaires, en réponse à un traitement par H2O2 (panneau inférieur).
Figure 2: Targeting a yellow fluorescent protein-based redox sensor (rxYFP) to the cytosol, nucleus and mitochondrial matrix of HeLa cells (upper panel) and time course analysis of compartment-specific redox changes in response to H2O2 treatments (lower panel).
Key publications
Year of publication 2018
Elie Hatem, Sandy Azzi, Nadine El Banna, Tiantian He, Amélie Heneman-Masurel, Laurence Vernis, Dorothée Baïlle, Vanessa Masson, Florent Dingli, Damarys Loew, Bruno Azzarone, Pierre Eid, Giuseppe Baldacci, Meng-Er Huang (2018 Nov 20)
Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer.
Journal of the National Cancer Institute : DOI : 10.1093/ije/djy149
Year of publication 2017
Elie Hatem, Nadine El Banna, Meng-Er Huang (2017 Nov 20)
Multifaceted roles of glutathione and glutathione-based systems in carcinogenesis and anticancer drug resistance.
Antioxidants & redox signaling : DOI : 10.1089/ars.2017.7134
Year of publication 2016
Meng-Er Huang, Céline Facca, Zakaria Fatmi, Dorothée Baïlle, Safia Bénakli, Laurence Vernis (2016 Jul 11)
DNA replication inhibitor hydroxyurea alters Fe-S centers by producing reactive oxygen species in vivo.
Scientific reports : 29361       : DOI : 10.1038/srep29361
Year of publication 2015
Tiantian He, Elie Hatem, Laurence Vernis, Ming Lei, Meng-Er Huang (2015 Dec 21)
PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug.
Journal of experimental & clinical cancer research : CR : 152   : DOI : 10.1186/s13046-015-0270-2
Year of publication 2014
Sandrine Ragu, Michèle Dardalhon, Sushma Sharma, Ismail Iraqui, Géraldine Buhagiar-Labarchède, Virginie Grondin, Guy Kienda, Laurence Vernis, Roland Chanet, Richard D Kolodner, Meng-Er Huang, Gérard Faye (2014 Sep 23)
Loss of the thioredoxin reductase Trr1 suppresses the genomic instability of peroxiredoxin tsa1 mutants.
PloS one : e108123     : DOI : 10.1371/journal.pone.0108123
Year of publication 2013
Agata Banach-Latapy, Tiantian He, Michèle Dardalhon, Laurence Vernis, Roland Chanet, Meng-Er Huang (2013 Dec 1)
Redox-sensitive YFP sensors for monitoring dynamic compartment-specific glutathione redox state.
Free radical biology & medicine : 436-45          : DOI : 10.1016/j.freeradbiomed.2013.07.033

- - - - -- -- - -
--- --- -   - --- ---